We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Chesnara Plc | CSN | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 1.00 | 0.40% | 254.00 | 16:35:13 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 254.00 | 252.50 | 255.00 | 254.00 | 253.00 |
| Industry Sector |
|---|
| LIFE INSURANCE |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 27/03/2025 | Final | GBP | 0.1608 | 03/04/2025 | 04/04/2025 | 20/05/2025 |
| 10/09/2024 | Interim | GBP | 0.0861 | 19/09/2024 | 20/09/2024 | 01/11/2024 |
| 28/03/2024 | Final | GBP | 0.1561 | 11/04/2024 | 12/04/2024 | 28/05/2024 |
| 21/09/2023 | Interim | GBP | 0.0836 | 28/09/2023 | 29/09/2023 | 10/11/2023 |
| 30/03/2023 | Final | GBP | 0.1516 | 06/04/2023 | 11/04/2023 | 26/05/2023 |
| Interim | GBP | 0.0812 | 08/09/2022 | 09/09/2022 | 21/10/2022 | |
| 31/03/2022 | Final | GBP | 0.1472 | 07/04/2022 | 08/04/2022 | 24/05/2022 |
| Interim | GBP | 0.0788 | 09/09/2021 | 10/09/2021 | 22/10/2021 | |
| 30/03/2021 | Final | GBP | 0.1429 | 08/04/2021 | 09/04/2021 | 24/05/2021 |
| Interim | GBP | 0.0765 | 08/10/2020 | 09/10/2020 | 13/11/2020 |
| Top Posts |
|---|
Posted at 03/4/2025 09:47 by lord gnome On a day when financial markets around the world are in turmoil, for CSN to fall by just a penny more than the ex-dividend amount shows real strength. No worries here. This is a share for people who like to spend their dividends and sleep soundly at night. |
Posted at 03/4/2025 08:51 by 1knocker The big drop (more than the dividend) does not augur well for the share price It suggests that the market sees the only value in these being the dividend, and the dividend at risk.I can only say that there has been an unbroken succession of dividend rises for many years, and the last accounts looked OK to me. Fingers crossed this continues to be an overlooked gem. Big drop for Phoenix on going Ex D today as well. |
Posted at 02/4/2025 14:46 by mirandaj "DIVIDEND DETAILS· The recommended final dividend of 16.1p per share is expected to be paid on 20 May 2025. The ordinary shares will be quoted ex-dividend on the London Stock Exchange as of 3 April 2025. The record date for eligibility for payment will be 4 April 2025." |
Posted at 02/4/2025 09:52 by kenmitch jubberjim/everyone. Anyone using this link should never need to ask about dividends again.That link is for the Chesnara dividends.Just enter the share code in the box to find each individual dividend. Also all the headings are well worth checking. So Chesnara goes ex dividend tomorrow.If you sell tomorrow you will get the dividend. Anyone buying tomorrow won’t get the dividend. Hence the term ex (excluding) the dividend. The 16p dividend is taken out of the share price first thing tomorrow. After first thing tomorrow what then happens to the share price, depends on the usual buying and selling.So the share price might fall by more than the dividend taken out of it or by less. Occasionally a lot of buying sees the share price end the ex dividend day higher despite the dividend being taken out of the price. |
Posted at 02/4/2025 05:32 by jubberjim I bought these as a hedge against Phnx shares soldBoth incidentally both PHNX Sell at 571 and CSN buy at 271 If I sell today will I still qualify for the dividend Was the reason behind the buy Thanks |
Posted at 28/3/2025 13:58 by 1knocker 20 yers is a long unbroken record for rising dividends.I first bought over a decade ago at 167, and for a while the share price moved up in step with the dividends, as one might expect. Then it flattened out to range between about 265 and 310. Then it fell below that range and became rather directionless, but generally trending down. Now it seems to be pushing up a bit, but with not much conviction. I fid it all rather baffling. Hey ho. Probably best not to worry too much about trying to understand the inscrutable ways of the market. Just play the ball where it lies, and reflect happily (as no doubt many others here can too) that the purchase cost of the holding is long since repaid and the income continues to roll in in increasing amounts. I have also held L&G over an even longer period (though without trading it), I bought at under £1, sold a third at £1.90 (which I came to regret) and that holding too has for some time been producing a 'free' income. had a little dabble in Phoenix last year, and that holding is currently 10% up and paying a big dividend too. Maybe we can see something the rest of the market can't, or maybe we have been walking down the middle of the road thinking the double while line is a safe pedestrian pathway and just been luckier than we deserve for the last decade or so. I don't know, but as the man who jumped off the building said as he passed the tenth floor window 'All good so far'. Best to live in the moment! |
Posted at 27/3/2025 07:59 by this_is_me Happy to keep collecting the almost 9% dividend yield (at yesterday's closing price) |
Posted at 27/3/2025 07:11 by wizzkid211 27 March 2025LEI Number: 213800VFRMBRTSZ3SJ06 Chesnara plc (CSN.L) ("Chesnara" or "the Company") CONTINUED STRATEGIC DELIVERY DRIVING GROWTH IN CASH GENERATION, FUTURE VALUE AND DIVIDENDS Chesnara reports its 2024 full year results. Key highlights are: · Cash Generation1 of £60m (FY 20231: £52m) grew by 14%, providing strong coverage of 1.60x (FY 2023: 1.45x) against the full year dividend; · Solvency Coverage Ratio of 203% (FY 2023: 205%) remained significantly above the upper-end of the Group's operating range of 140% - 160%, providing significant flexibility to allocate capital to M&A and other investment opportunities; · Economic Value (EcV) Earnings of £69m (FY 2023: £59m) grew by 17% supporting growth in the Group's EcV per share to 352p (FY 2023: 348p) after dividend payments; · IFRS pre-tax profits increased to £21m (FY 20232: £2m); with IFRS pre-tax Contractual Services Margin (CSM) growing to £176m (FY 20232: £157m), increasing the store of future value from the Group's insurance portfolio; · New Business Contribution was stable at £9m (FY 2023: £10m); · Ongoing M&A momentum with announcement of Canada Life portfolio transfer in December 2024, adding £11m of EcV which was £3m higher than previously announced; · The Board is recommending a 3% increase in the final dividend to 16.1p per share. Total dividend for FY 2024 of 24.7p per share. Commenting on the results, Steve Murray, Group CEO, said: "We have again delivered a strong set of financial results with increased Cash Generation, positive organic EcV Earnings and a robust solvency position. This financial performance has allowed us to extend our track record of uninterrupted full year dividend growth to 20 years, unrivalled across listed UK and European insurers. Our people have also continued to deliver on our major operational programmes and our second portfolio acquisition from Canada Life again demonstrates our ability to grow through M&A and deliver very attractive returns for shareholders. Our M&A pipeline remains positive, and we continue to have significant firepower to deploy on opportunities." A full year results presentation is being held at 10:00am on 27 March 2025 - participants can register here. Further details on the financial results are as follows: |
Posted at 25/3/2025 19:32 by 1knocker As a matter of fact, it has gone worse than nowhere. For several years the share price has been flat or down, notwithstanding a steady rise in the dividend.It used to range very reliably between about 265 and 315, making an easy trade in and out inside those parameters and (with care and a bit of luck) without dropping any dividends. I used to set the appropriate limit orders and just wait. i used to add a few shares and slightly reduce my capital committed on each 'turn', over time building quite a decent holding which has paid for itself with that strategy plus the dividends. I would very much like to be able to get back to applying that formula! |
Posted at 23/12/2024 21:11 by cerrito I got this from Proactivequote CSN’s latest acquisition from Canada Life UK is small but 'highly attractive' according to analysts at Panmure Liberum. The life and pensions group is acquiring £1.5bn assets under administration across 17,000 unit-linked policies for a total consideration of £2 million. By focusing on unit-linked policies, Chesnara should see “an incredibly fast payback period and uplift to cash generation,” adds the broker, adding to its predictable cash generation, which ultimately supports the uninterrupted dividend growth trajectory. “Moreover, this still leaves management with all the firepower to conduct a larger transaction next year should the opportunity present itself.” “To this end, the new policy administration partnership bodes well for migrating policies at scale and generating further efficiencies over time. Although not a large deal, Panmure Liberum suggests it is one of Chesnara’s most attractive on a purely financial metrics basis. The discount to EcV [economic value] means an immediate uplift of £8 million via a reinsurance agreement, while the deal should generate £8 million of cash over five years. More M&A is likely, adds Panmure, with Chesnara having a liquidity position of £200 million through ready cash and a revolving credit facility. In addition, “assuming management keeps its debt leverage at around 30% of its IFRS capital base”, the broker suggests an acquisition with c£300 million of value could provide for an additional debt capacity of c£100 million. “We get the sense management may be willing to participate in larger M&A than in the recent past, especially if traditional competitors and PE houses are focused elsewhere. “Larger peers are trying to focus on organic new business opportunities, while private equity-backed players now have a higher regulatory hurdle. Management has carried out due diligence on several possible transactions, adds Panmure Liberum, with a strong pipeline for the next 6-12 months for value-enhancing transactions. Regulatory metrics are also strong with a Solvency II coverage ratio of 201% at 1H24 (FY23: 205%), compared to a target range of 140%-160%, which implies excess capital above the top end of the target range of £134 million. “This was partly helped by a well-timed tier 2 debt issuance in 2022 and points to the M&A capacity management has on a standalone basis.” Panmure adds that with £200 million of firepower “We expect management to acquire additional insurance portfolios”. Now is a sensible time to be an acquirer as life insurers continue to battle inflation, legacy systems and operational challenges associated with run-off books, it adds. “We also continue to expect a steady flow of new business, which has historically supported around one-third of the dividend cost. “The move to the new outsourcing policy administration partner SS&C will allow for the migration of future acquisitions at scale and bodes well for efficiency improvements.” In conclusion, Panmure says that Chesnara is underrated given trends currently in the life sector. “With a well-timed Tier 2 debt issue and solid balance sheet, management is well positioned to take advantage of closed Life Insurance consolidation. “The Economic Value (EcV) is not immune to market volatility, but a clear vision and focus on value & dividend enhancing acquisitions and new business gives us confidence the EcV will continue to grow through the cycle.” Currently, Panmure estimates the shares trade on a 23% discount to June’s EcV number of 337p, “Which fails to reflect the growth opportunities, outlook, and realistic value of the business”. In addition, the estimated 2024 dividend yield is an attractive 9.6% and 'likely to continue to grow'. 'Buy' with a target price of 420p is its recommendation. Shares today were unchanged at 258p. The formal transfer via the UK courts of the Canada Life portfolio is scheduled to take place at the end of 2025. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
